PRPHProPhase Labs, Inc.
0.0857USD-22.09%Mkt Cap: 405961 USDP/E: Last update: 2026-05-26

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a ra…

Indicators:|

Key Statistics

Company
Market Cap405.96K USD
Enterprise Value9.33M USD
Revenue (TTM)4.90M USD
Gross Profit-150.00K USD
Net Income (TTM)-53.36M USD
Revenue/Share0.5770 USD
Last Price0.0857 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN
Valuation
P/E (Trailing)
P/E (Forward)0.19
PEG
EV/EBITDA-0.78
EV/Revenue1.91
P/S0.09
P/B0.16
EPS (TTM)-19.80
EPS (Forward)0.48
52W Range
0.07000% of range6.700
52W High6.700 USD
52W Low0.0700 USD
Profitability
Gross Margin-2.22%
Oper. Margin-330.25%
EBITDA Margin-243.08%
Profit Margin-788.24%
ROE-725.74%
ROA-84.44%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-17.54M USD
CapEx (TTM)906.00K USD
FCF Margin876.75%
FCF Yield10582.51%
Net Debt8.53M USD
Net Debt/EBITDA-0.72
Balance Sheet
Debt/Equity3.34
Current Ratio0.11
Quick Ratio0.04
Book Value/Sh0.5460 USD
Cash/Share0.0100 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div DateMay 24, 2022
Pay DateJun 3, 2022
Splits
Last Split1:10
Split DateDec 22, 2025
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.4.74M
Float8.65M
Insiders5.05%
Institutions0.15%
Short Interest
Short Ratio0.1d
Short % Float0.71%
Short % Out.0.65%
Shares Short30.02K
Short (prev mo.)8.96K
Technical
SMA 500.1116 (-23.2%)
SMA 2001.717 (-95.0%)
Beta0.17
S&P 52W Chg28.31%
Avg Vol (30d)67.02K
Avg Vol (10d)21.82K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)